AstraZeneca Pharma Q3 Results: Profit nearly doubles, margin expands sharply

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.

Leave a Reply

Your email address will not be published. Required fields are marked *